1 / 44

Organ Pathology

Organ Pathology. Female Genital System - II. Pathology of ovaries, tubes, breast, pregnancy. Jaroslava Dušková Inst. Pathol. ,1st Med. Faculty, Charles Univ. Prague http://www1.lf1.cuni.cz/~jdusk/. Diseases of the Fallopian Tubes. inborn – malformations:

inezbrown
Télécharger la présentation

Organ Pathology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Organ Pathology Female Genital System - II Pathology of ovaries, tubes, breast, pregnancy Jaroslava Dušková Inst. Pathol. ,1st Med. Faculty, Charles Univ. Prague http://www1.lf1.cuni.cz/~jdusk/

  2. Diseases of the Fallopian Tubes • inborn – malformations: • aplasia (Müllerian duct disorders) • bilateral incl. uterus & vagina • unilateral incl. kidney • partial atresia • acquired

  3. Diseases of the Fallopian Tubes • inborn • acquired • non neoplastic : atrophy, infection – pyosalpinx, hydrosalpinx, tbc salpingitis, synechiae • salpingitis isthmica nodosa • pseudotumours – cysts, ectopic pregnancy, • neoplastic: adenocarcinoma

  4. Diseases of the Fallopian Tubes & Ovaries • PID – pelvic inflammatory disease (chronic salpingooophoritis) • tubar sterility

  5. Diseases of the Ovaries • inborn • acquired • non-neoplastic • pseudotumours • neoplastic • benign • BORDERLINE • malignant (cont.)

  6. Diseases of the Ovaries • inborn – malformations: • aplasia (incl. kidney, uterus & vagina), • hypoplasia/dysplasia (e.g. in adrenogenital syndrome –pseudohermafroditismus femininus, Turner sy (45X0, or 45X0/46XX) • acquired (cont.)

  7. Diseases of the Ovaries • inborn • acquired • non-neoplastic • atrophy - involution, inflammation – PID, actinomycosis, tbc • pseudotumours • neoplastic • benign • BORDERLINE • malignant (cont.)

  8. Diseases of the Ovaries • inborn • acquired • non-neoplastic • pseudotumours • stromal hyperplasia • CYSTS • neoplastic • benign • BORDERLINE • malignant (cont.)

  9. Ovary - cysts • follicle • luteal • inclusion • endometrial („chocolate“) • POLYCYSTIC OVARIES(Stein- Leventhal syndrome) • obesity • hirsutism • infertility • oligo- or amenorrhea

  10. Diseases of the Ovaries • inborn • acquired • pseudotumours (stromal hyperplasia, dif. dg. CYSTS) • TUMOURS

  11. TUMOURS of the Ovary119 (!) coded nosology units ICD-OClassification groups • Surface epithelial stromal • Sex cord stromal • Germ cell • Mixed germ cell sex cord-stromal • Tumour of the rete ovarii • Miscelaneous, tumour like lesions • Lymphomas & leukemias • Secondary tumours of the ovary • Peritoneal tumours

  12. Ovary malignant neoplasms • Czech Rep. 1323 new cases 2002 • Czech Rep. 25,3/ 100 000 women • Europe 20,6/ 100 000 women • World 15,1/ 100 000 women

  13. TUMOURS of the Ovary Surface epithelial stromal tumours • 30% of fem. gen. neoplasms • middle & old age • risk factors: longer HRT, obesity • protective factors: high parity, oral contraceptives • precursors: inclusion cyts, endometriosis • lack of early warning symptoms • 70% dg. at a late stage – ca peritonitis • mean 5-year survival in Europe 32% (!!!)

  14. TUMOURS of the Ovary Surface epithelial stromal tumours - macroscopy • small to more than 20cm • two thirds bilateral • solid & cystic with intracystic papillae • confluent papillae, softer borderline • necroses & haemorrhage susp. malignancy

  15. serous - endosalpigeoma mucinous – endocervicoma mixed endometrioid (coinciding with endometrial ca) Brenner tumour ------------------------ papillary cystadenoma papillary borderline papillary cystadenocarcinomas TUMOURS of the Ovary Surface epithelial stromal tumours - microscopy

  16. TUMOURS of the Ovary119 (!) coded nosology units ICD-OClassification groups • Surface epithelial stromal • Sex cord stromal • Germ cell • Mixed germ cell sex cord-stromal • Tumour of the rete ovarii • Miscelaneous, tumour like lesions • Lymphomas & leukemias • Secondary tumours of the ovary • Peritoneal tumours

  17. TUMOURS of the Ovary Sex cord stromal tumours • Granulosa-stromal cell tumours • Thecoma-fibroma group • Sertoli- Leydig cell group • Others…..

  18. TUMOURS of the Ovary Sex cord stromal tumours Granulosa-stromal cell tumours • manifesting mostly as a solid or cystic mass or with steroid hormones productionE/A effects • adult • juvenile • bleeding disorders, virilisation, • isosexual precoccious puberty

  19. TUMOURS of the Ovary119 (!) coded nosology units ICD-OClassification groups • Surface epithelial stromal • Sex cord stromal • Germ cell • Mixed germ cell sex cord-stromal • Tumour of the rete ovarii • Miscelaneous, tumour like lesions • Lymphomas & leukemias • Secondary tumours of the ovary • Peritoneal tumours

  20. TUMOURS of the OvaryGerm cell Tumours • dysgerminoma (= seminoma ovarii) • embryonal carcinoma • teratoma (mature, immature) • yolc sac tumour • choriocarcinoma

  21. Embryonal carcinoma • composed of primitive anaplastic-appearing epithelial cells • pure rare, mostly in combined germ cell tumours • peak incidence 30 years • swelling, 2/3 patients with metastases at diagnosis • macro : tan/gray, necroses, hemorrhages • micro: solid, tubular, PLAP, CK +

  22. Mesoblastoma vitellinum- yolc sac tumour –endodermal sinus tumour • 80% of prepubertal germ cell tumours • in postpubertal as admixture • painless mass, serum AFP elevated • macro: gray/tan nonencapsulated • micro: many variants – microcystic, solid,festoon-like, hepatoid, spindle cell… • AFP+, alpha1-Antitrypsin

  23. Choriocarcinoma (non gestational) • rare • admixture in many germ cell tumours • malignant • children & young adults • presents with bleeding and precoccious pseudopuberty • ß-HCG + morphologicall identical with gestational ch.

  24. Teratomas Def.: Tumours (benign, borderline or malignant) composed of two or more different cell lines that are NOT normally present in the place of tumour origin

  25. Teratoma • coetaneous – differentiated -cystic • embryonal – nondifferentiated - solid

  26. TUMOURS of the OvarySecondary tumours of the ovary • metastatic - advanced stage • poor prognosis • Krukenberg tumour – metastatic signet ring cell ca originating mostly in the stomach or colon

  27. Diseases of the Breast • inborn – malformations: • amastia, polymastia (mamma accessoria), aberant mammary tissue, polythelia • acquired

  28. Diseases of the Breast • inborn • acquired • degenerations:amyloid, mastitis: acute puerperal, chronic • Pseudotumours (& precanceroses) : fibrocystic disease, lipophagic granuloma, silicon granuloma, suture granuloma…. • TUMOURS

  29. Fibrocystic Breast Disease Def: dyshormonal changes of the breast tissue with variably increased risk of breast cancer according to the type of epithelial proliferation

  30. Fibrocystic Breast Disease - symptoms • palpable lump • fluctuating cysts • (pain)

  31. Fibrocystic Breast Disease - morphology • fibrosis • cysts • epithelial hyperplasia • ductal, lobular – adenosis :simple, florid, sclerosing, microglandular • usual, atypical • papillary

  32. Tumours of the BreastWHO 200375 ICD-O coded nosology units • epithelial • myoepithelial • mesenchymal • fibroepithelial • tumours of the nipple • malignant lymphoma • metastatic tumours • tumours of the male breast

  33. Tumours of the Breast symptoms • early stage – asymptomatic – mammography – (microcalciffication) • palpable lump • nipple discharge • breast configuration change • ulceration • metastases

  34. Benignepithelial tumours • intraductal papilloma - central - peripheral • tubular adenoma

  35. Breast cancer – high risk • age more than 50 • developed countries USA, Europe • positive family history • atypical hyperplasia • BRCA1 gen (40-50%), BRCA2 gen, + other ca (bowel, ovary, prostate, stomach, pankreas..)

  36. Breast cancer – increased risk • menarche prior 11 & menopause after 55 yrs • nuliparity late first delivery 30-35 let • higher socioeconomic group • obesity • radiation

  37. Breast cancer – increased risk • etanol abuse • oral contraceptives uncertain • HRT following 10-15 yrs administration

  38. Ductal ca in situ DCIS • TDLU, seldom larger ducts • precursor of invasive ca • microcalcification on mammography 85% of cases detected with imaging techniques screening introduction incidence from 2,4/ 100 000 to 15,8/ 100 000

  39. Ductal ca in situ DCIS Histopathology • solid, papillary, cribriform, comedo • cytology (grading) G1-3

  40. Lobular carcinoma in situ LCIS • 85% multicentric, 30% bilateral • precursor of invasive ca Histopathology: • preserved lobular architecture, TDLU involvement, small monomorphous cells, regular nuclei

  41. Breast cancer -prognosis • typing • grading • staging • hormonal receptors (ER & PR- immunohistochemistry) • c-erbB-2 receptoru (immunohistochemistry, FISH) • proliferation activity (immunohistochemistry Ki-67 index) • angioinvasion

  42. Mixed Tumours Def.: Tumours (benign or malignant) composed of two or more different cell lines that are normally present in the place of tumour origin

  43. Fibroadenoma • young age (30yr) • firm circumscribed, painles • mostly up to 30 mm • solitary • stromal & epithelial component

  44. Phyllodestumor • middle age (50yrs) • mostly benign, recurrences • painless, up to 50 mm • more cellular stromal component

More Related